Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,707	10,304	15,470	7,683	2,784	1,858
Short-Term Investments	99,589	106,771	121,604	185,173	91,803	88,646
Trading Asset Securities	-	-	276	-	-	-
Cash & Short-Term Investments	110,295	117,075	137,350	192,856	94,587	90,504
Cash Growth	-5.16%	-14.76%	-28.78%	103.89%	4.51%	99.25%
Accounts Receivable	5,198	8,022	11,625	6,358	5,206	4,186
Other Receivables	419.02	513.16	1,425	3,428	661.09	381.36
Receivables	15,105	17,643	20,207	10,312	5,986	4,676
Inventory	10,277	12,113	14,946	9,794	8,355	9,178
Prepaid Expenses	98.9	78.09	134.77	73.65	169.68	95.17
Other Current Assets	1,294	1,321	1,837	7,277	685.8	546.39
Total Current Assets	137,070	148,230	174,475	220,313	109,783	104,999
Property, Plant & Equipment	22,235	24,160	26,164	23,294	15,431	15,669
Long-Term Investments	996	975.89	1,574	476.43	486.51	456.03
Goodwill	1,480	1,480	1,480	-	-	-
Other Intangible Assets	3,378	3,724	4,371	2,186	6,469	1,968
Long-Term Deferred Tax Assets	612.29	612.97	571.39	-	-	-
Long-Term Deferred Charges	-	-	-	0	-	1.17
Other Long-Term Assets	1,811	2,537	2,859	1,233	884.1	625.98
Total Assets	168,072	181,744	211,546	247,555	133,084	123,802
Accounts Payable	1,826	2,514	6,493	1,496	2,250	867.65
Accrued Expenses	5.18	7.97	10.21	59.78	16.12	15.77
Short-Term Debt	3,060	3,410	2,280	33,750	45,629	4,380
Current Portion of Long-Term Debt	155.25	425	1,113	2,492	2,867	1,058
Current Portion of Leases	274.26	699.55	654.19	344.64	126.7	191.28
Current Income Taxes Payable	-	18.5	-	-	-	-
Other Current Liabilities	2,487	4,299	3,603	4,142	2,732	3,271
Total Current Liabilities	7,808	11,375	14,154	42,284	53,621	9,784
Long-Term Debt	536.68	-	1,025	683.32	3,175	37,120
Long-Term Leases	113.24	345	584.45	509.09	179.98	317.11
Pension & Post-Retirement Benefits	1,579	1,079	440.23	2,334	627.21	1,404
Long-Term Deferred Tax Liabilities	633.05	668.21	715.09	-	819.58	2,695
Other Long-Term Liabilities	6,983	6,795	0	0	0	-0
Total Liabilities	17,653	20,261	16,919	45,811	58,422	51,320
Common Stock	42,533	42,533	42,533	42,144	4,166	4,124
Additional Paid-In Capital	108,957	108,957	108,431	309,804	194,149	164,219
Retained Earnings	11,250	19,530	41,910	-151,053	-124,665	-95,176
Treasury Stock	-13,675	-10,822	-	-	-	-
Comprehensive Income & Other	148.08	155.98	641.6	580.01	822.79	-707.74
Total Common Equity	149,212	160,353	193,516	201,474	74,472	72,458
Minority Interest	1,206	1,130	1,111	-	-	-
Shareholders' Equity	150,418	161,483	194,627	201,744	74,662	72,483
Total Liabilities & Equity	168,072	181,744	211,546	247,555	133,084	123,802
Total Debt	4,139	4,880	5,657	37,779	51,977	43,067
Net Cash (Debt)	106,156	112,195	131,693	155,077	42,609	47,437
Net Cash Growth	-5.01%	-14.81%	-15.08%	263.95%	-10.18%	12.06%
Net Cash Per Share	1355.86	1368.88	1550.62	1967.48	843.86	976.40
Filing Date Shares Outstanding	76.89	79.62	85.07	84.29	49.99	49.48
Total Common Shares Outstanding	76.89	79.62	85.07	84.29	49.99	49.48
Working Capital	129,262	136,855	160,321	178,028	56,163	95,215
Book Value Per Share	1940.58	2014.00	2274.90	2390.31	1489.80	1464.30
Tangible Book Value	144,354	155,150	187,665	199,289	68,003	70,490
Tangible Book Value Per Share	1877.40	1948.64	2206.12	2364.38	1360.38	1424.53
Land	8,249	8,249	8,090	6,249	6,249	6,249
Buildings	9,916	9,855	9,883	9,055	6,092	6,092
Machinery	21,379	21,579	21,252	18,549	14,238	12,790
Construction In Progress	-	89	122.75	68.5	194.46	559.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.